Old Web
English
Sign In
Acemap
>
authorDetail
>
Wei Ma
Wei Ma
Biogen Idec
Medicine
Internal medicine
Daclizumab
Physical therapy
stock options
4
Papers
2
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Efficacy of daclizumab beta versus intramuscular interferon beta-1a on disability progression across patient demographic and disease activity subgroups in DECIDE:
2018
Multiple Sclerosis Journal
Stanley Cohan
Ludwig Kappos
Gavin Giovannoni
Heinz Wiendl
Krzysztof Selmaj
Eva Havrdova
John Rose
Steven M. Greenberg
Glenn Phillips
Wei Ma
Ping Wang
Gabriel Lima
Guido Sabatella
Show All
Source
Cite
Save
Citations (2)
Daclizumab Reduced Brain Tissue Loss Compared With Intramuscular Interferon Beta-1a in the 2–3 Year DECIDE Study (S12.001)
2017
Neurology
John W. Rose
Douglas L. Arnold
David Hojnacki
Steven J. Greenberg
Ping Wang
Wei Ma
Sami Fam
Show All
Source
Cite
Save
Citations (0)
PO111 Daclizumab efficacy in highly active rrms: select/decide
2017
Journal of Neurology, Neurosurgery, and Psychiatry
Gavin Giovannoni
Tjalf Ziemssen
Wei Ma
Sami Fam
Show All
Source
Cite
Save
Citations (0)
Tentative and Confirmed Disability Progression in MS Clinical Trials (P2.115)
2016
Neurology
Jacob Elkins
Ludwig Kappos
Krzysztof Selmaj
Wei Ma
Katherine Riester
Show All
Source
Cite
Save
Citations (0)
1